Tohoku University. Research Profiles

LANGUAGE

Drug Delivery System for Retinal Protection

update:2018-12-21
  • JAPANESE
  • INQUIRY
  • seed-104-1-en.jpg
  • seed-104-2-en.jpg
NEXT
PREV
Features
Intravitreal injection of some drugs to treat retinal diseases has been successfully reported. However, there is a possibility of severe side effects, such as infection. So we have developed a transscleral drug delivery system by using non-biodegradable device, which enabled sustained drug delivery to the retina. Because of the nature of the device, we can deliver the multi-drug independently. We have performed our work in collaboration with Department of Bioengineering and Robotics.

Targeted Application(s)/Industry
Using this drug delivery device, we may be able to apply our system not only to the retinal diseases but also to other diseases.
For clinical application, we hope the collaboration with companies and organizations from the points of materials and original drug delivery to the focal regions.

Researchers

Division of Clinical Cell Therapy, Graduate School of Medicine

ABE, Toshiaki , Professor
MD

Keywords

List